- Home
- Products
COSELA (Trilaciclib)
COSELA (Trilaciclib)
- Medicine Name: Cosela
- Generic Name: Trilaciclib
- Dosage Form & Strength: Injection – 300 mg per vial
- Manufactured By: G1 Therapeutics, Inc.
Cosela is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor approved to reduce the incidence of chemotherapy-induced myelosuppression in adult patients receiving:
- Platinum/etoposide-containing regimen, or
- Topotecan-containing regimen
for extensive-stage small cell lung cancer (ES-SCLC).
Recommended Dosage:
- 240 mg/m² IV infusion over 30 minutes
- Complete infusion within 4 hours before chemotherapy
- Administer on each day chemotherapy is given
- Do not exceed 28 hours between doses on consecutive days
If a dose is missed, skip chemotherapy for that day. Resume Cosela + chemotherapy the next scheduled day.
Injection Site Reactions: May cause phlebitis or thrombophlebitis. Monitor for redness, pain, or swelling at the infusion site.
Hypersensitivity Reactions: Facial edema, urticaria, or anaphylaxis may occur. Discontinue immediately if severe reactions present.
Interstitial Lung Disease (ILD)/Pneumonitis: Can be fatal. Monitor for symptoms like cough, dyspnea, and hypoxia. Discontinue in moderate-to-severe cases.
Fetal Harm Risk: Can harm an unborn baby. Use contraception during treatment and for 3 weeks after the final dose.
Breastfeeding Restriction: Do not breastfeed during treatment and for 3 weeks post-final dose.
Required Documents to Import Cosela to India:
- Valid prescription from a licensed oncologist
- Diagnostic reports related to SCLC treatment plan
- Government-issued photo ID of the patient
Order Confirmation:
- Confirmed only after receipt of required documents and import permit (if applicable)
Availability in India & Globally: Available in Mumbai, Delhi, Hyderabad, Chennai, Kolkata, Ahmedabad, Bangalore, Pune, and more. Also available for export under Named Patient Program.
To Order or Enquire Price:
- 📞 Call/WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Cosela from certified suppliers in the USA, Canada, Europe, and Australia. Each order is:
- Validated by pharmacists
- Packed with regulatory compliance
- Dispatched from our fulfillment center in Ambernath, Thane District
We ensure safe international delivery, quality assurance, and legal transparency.
What is the generic name of Cosela®?
Trilaciclib
Who manufactures Cosela®?
G1 Therapeutics, Inc.
FDA approval date?
Yes. Approved on February 12, 2021
What is Cosela® used for?
To reduce chemotherapy-induced myelosuppression in patients with ES-SCLC
What is the dosage form?
Injection: 300 mg single-dose vial for IV use
Common side effects?
Fatigue, low potassium/calcium/phosphate levels, elevated liver enzymes, headache, and pneumonia
How much does Cosela® cost in India?
Price may vary. For the latest pricing, contact us via WhatsApp: +91-99675 15602 or email info@globalraremeds.com
How should Cosela® be stored?
Store at 20–25°C (68–77°F), excursions allowed between 15–30°C (59–86°F). Protect from light. Do not freeze.
Is it safe to order Cosela® online in India?
Yes. Global Rare Meds ensures safe, legal access to Cosela under the Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
